Cartesian Therapeutics, Inc. Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants
Cartesian Therapeutics, Inc. (RNAC) reported Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants of $3.65 million for the 12-month period ending 2015-12-31, per its 10-K filed 2018-03-15.
Discontinued › Notes › Equity › Stockholders' Equity Note
us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants · last filed 2018-03-15
- Cartesian Therapeutics, Inc. stock and warrants issued during period, value, preferred stock and warrants for fiscal 2015 was $3.65M.
| Period end | Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants 12 month |
|---|---|
| 2015-12-31 | $3.65M 10-K · filed 2018-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |